Italy· 034463048
ALIFLUS DISKUS
A salmeterol and fluticasone product containing salmeterolo/fluticasone, registered in Italy by MENARINI INTERNAT. O.L.S.A, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against AIFA (Italy) on
Informational only — not a medical device.
Where it is registered
Salmeterol and fluticasone is registered in 14 of 19 countries.
Countries holding a registration under ATC R03AK06 (salmeterol and fluticasone), each read from that country’s own register.
- This record: Italy, from AIFA (Italy)
- 9 of them publish a price we can compare per daily dose
Salmeterol and fluticasone · ATC R03AK06
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
AIFA (Italy)- Active substance
- Salmeterolo/fluticasone
- Manufacturer
- MENARINI INTERNAT. O.L.S.A
- Country
- Italy (IT)
- ATC code
- R03AK06
- ATC class
- Salmeterol and fluticasone
- Defined daily dose
- 0.1 mg, Inhal
- Reimbursed
- Yes
- Source register
- AIFA (Italy)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- aic034463048DISKUS 50/100 POLVERE PER INALAZIONE 1 INALATORE 60 DOSI 50 MCG + 100 MCGEUR 18.51
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
718 interactions on record for salmeterol and fluticasone.
Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Salmeterol and fluticasone · interactions on record
718 records
- 49 severe
- 397 moderate
- 24 minor
- 248 info
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- PindololC07AA03severe
- PropranololC07AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R03AK06
Salmeterol and fluticasone, as other registers publish it.
- United StatesADVAIRA-S Medication Solutions
- United StatesADVAIRA-S Medication Solutions
- United StatesADVAIRA-S Medication Solutions
- United StatesADVAIRGlaxoSmithKline LLC
- United StatesADVAIRGlaxoSmithKline LLC
- United StatesADVAIRA-S Medication Solutions
- United StatesADVAIRGlaxoSmithKline LLC
- CanadaADVAIRGLAXOSMITHKLINE INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c06b725b-8056-4031-810d-ad18cc917293 GET /v1/drugs/c06b725b-8056-4031-810d-ad18cc917293?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pack": "DISKUS 50/100 POLVERE PER INALAZIONE 1 INALATORE 60 DOSI 50 MCG + 100 MCG",
"source": "aifa",
"currency": "EUR",
"substance": "Salmeterolo/fluticasone",
"reference_pack": "60 DOSI 50 MCG+100 MCG - USO RESPIRATORIO",
"public_price_eur": 18.51,
"ssn_reference_price_eur": 24.31
}See everything about salmeterol and fluticasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.